Endeavor

Triplet Therapy Shows Promise in Advanced Lung Cancer

EVOKE-02 study marks an innovative and unconventional approach

World Lung Cancer Day Spotlights Need for Critical Screenings

In 2022, only 4.5% of eligible Americans were screened for the disease

Landmark Lung Cancer Studies Set to Alter Standard of Care

New data reveals significant survival benefits for patients with stage 3 unresectable non-small cell and limited-stage small cell lung cancers

Fighting Lung Cancer, One Step at a Time

Miles for Moffitt gives patients like Kathryn VonAldenbruck a chance to show they are thriving in the moment while raising money for the breakthroughs of tomorrow

Malnutrition Plays Role in Treatment Response, Study Shows

Lung cancer patients with recent weight loss had worse response to immunotherapy

Study Explores mRNA Vaccine Combo Therapy for Advanced Non-Small Cell Lung Cancer

Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy

Miles for Moffitt Keeps Researchers on Pace to Find New Cancer Treatments

Series of grants brings together top scientists and clinicians to study how lung tumors metabolize nutrients

Combination Therapy Shows Mixed Results in First Randomized Trial for Lung Cancer

Tumor shrinkage is a positive sign, but overall survival rates did not improve

Can Viruses Be Used to Treat Lung Cancer?

Oncolytic virus therapy stimulates immune system to target cancer cells